Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 18:15:95.
doi: 10.1186/s12894-015-0089-3.

Chromosomal abnormalities and Y chromosome microdeletions in infertile men from Morocco

Affiliations

Chromosomal abnormalities and Y chromosome microdeletions in infertile men from Morocco

Yassine Naasse et al. BMC Urol. .

Abstract

Background: Male infertility is responsible for 50% of infertile couples. Thirty percent of male infertility is due to cytogenetic and genetic abnormalities. In Arab and North African populations, several studies have shown the association of these chromosomal abnormalities with male infertility. Our objective is to evaluate the frequency of chromosomal abnormalities and Y chromosome microdeletions in infertile men from Morocco.

Methods: A total of 573 Moroccan infertile men (444 azoospermic and 129 oligozoospermic men) referred for cytogenetic analysis to the Department of Cytogenetics of the Pasteur Institute of Morocco, were screened for the presence of chromosomal abnormalities and Y chromosome microdeletions.

Results: Chromosomal abnormalities accounted for approximately 10.5% (60/573). Fifty six cases among them have sex chromosome abnormalities (93.34%), including Klinefelter's syndrome in 41 patients (68.34%). Autosomal chromosome abnormalities (6.66%) were observed in 4 patients. Chromosomal abnormalities were more prevalent in azoospermic men (13.06%) than in oligospermic men (1.55%). Y microdeletions were detected in 16 of 85 patients (AZFc: 14.12%, AZFbc: 4.70%), most of them where azoospermic men with no chromosomal abnormality.

Conclusions: These results highlighted the need for efficient molecular genetic testing in male infertility diagnosis. In addition, a genetic screening should be performed in infertile men before starting assisted reproductive treatments.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Van Assche E, Bonduelle M, Tournaye H, Joris H, Verheyen G, Devroey P, et al. Cytogenetics of infertile men. Hum Reprod. 1996;4:1–24. doi: 10.1093/humrep/11.suppl_4.1. - DOI - PubMed
    1. Gurunath S, Pandian Z, Anderson RA, Bhattacharya S. Defining infertility – a systematic review of prevalence studies. Hum Reprod Update. 2011;17:575–88. doi: 10.1093/humupd/dmr015. - DOI - PubMed
    1. Kim ED, Lipshultz LI. Male subfertility: diagnostic and therapeutic advances. Br J Urol. 1997;80(4):633–41. doi: 10.1046/j.1464-410X.1997.00378.x. - DOI - PubMed
    1. Ferlin A, Arredi B, Foresta C. Genetic causes of male infertility. Reprod Toxicol. 2006;22:133–41. doi: 10.1016/j.reprotox.2006.04.016. - DOI - PubMed
    1. Kosar PA, Ozcelik N, Kosar A. Cytogenetic abnormalities detected in patients with non-obstructive azoospermia and severe oligozoospermia. J Assist Reprod Genet. 2010;27:17–21. doi: 10.1007/s10815-009-9366-y. - DOI - PMC - PubMed

Publication types

Supplementary concepts

LinkOut - more resources